GB201020300D0 - Product - Google Patents

Product

Info

Publication number
GB201020300D0
GB201020300D0 GBGB1020300.8A GB201020300A GB201020300D0 GB 201020300 D0 GB201020300 D0 GB 201020300D0 GB 201020300 A GB201020300 A GB 201020300A GB 201020300 D0 GB201020300 D0 GB 201020300D0
Authority
GB
United Kingdom
Prior art keywords
cardiopulmonary bypass
relates
present
oncotic
priming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1020300.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vitrolife Sweden AB
Original Assignee
Vitrolife Sweden AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitrolife Sweden AB filed Critical Vitrolife Sweden AB
Priority to GBGB1020300.8A priority Critical patent/GB201020300D0/en
Publication of GB201020300D0 publication Critical patent/GB201020300D0/en
Priority to EP11788089.8A priority patent/EP2646040B1/en
Priority to JP2013541272A priority patent/JP6051164B2/ja
Priority to US13/634,934 priority patent/US8969323B2/en
Priority to ES11788089.8T priority patent/ES2575206T3/es
Priority to CN201180056991.XA priority patent/CN103228285B/zh
Priority to PL11788089T priority patent/PL2646040T3/pl
Priority to RU2013127665/15A priority patent/RU2013127665A/ru
Priority to PCT/EP2011/069524 priority patent/WO2012072374A1/en
Priority to DK11788089.8T priority patent/DK2646040T3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
GBGB1020300.8A 2010-11-30 2010-11-30 Product Ceased GB201020300D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB1020300.8A GB201020300D0 (en) 2010-11-30 2010-11-30 Product
DK11788089.8T DK2646040T3 (en) 2010-11-30 2011-11-07 CARDIOPULMONAL BYPASS PRIMING SOLUTIONS
ES11788089.8T ES2575206T3 (es) 2010-11-30 2011-11-07 Disoluciones de cebado para derivación cardiopulmonar
JP2013541272A JP6051164B2 (ja) 2010-11-30 2011-11-07 心肺バイパス用プライミング液
US13/634,934 US8969323B2 (en) 2010-11-30 2011-11-07 Priming solutions for cardiopulmonary bypass
EP11788089.8A EP2646040B1 (en) 2010-11-30 2011-11-07 Priming solutions for cardiopulmonary bypass
CN201180056991.XA CN103228285B (zh) 2010-11-30 2011-11-07 用于心肺转流术的预充液
PL11788089T PL2646040T3 (pl) 2010-11-30 2011-11-07 Roztwory wypełniające do stosowania w pomoście sercowo-płucnym
RU2013127665/15A RU2013127665A (ru) 2010-11-30 2011-11-07 Раствор для первичного заполнения аппарата искусственного кровообращения
PCT/EP2011/069524 WO2012072374A1 (en) 2010-11-30 2011-11-07 Priming solutions for cardiopulmonary bypass

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1020300.8A GB201020300D0 (en) 2010-11-30 2010-11-30 Product

Publications (1)

Publication Number Publication Date
GB201020300D0 true GB201020300D0 (en) 2011-01-12

Family

ID=43500877

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1020300.8A Ceased GB201020300D0 (en) 2010-11-30 2010-11-30 Product

Country Status (10)

Country Link
US (1) US8969323B2 (enExample)
EP (1) EP2646040B1 (enExample)
JP (1) JP6051164B2 (enExample)
CN (1) CN103228285B (enExample)
DK (1) DK2646040T3 (enExample)
ES (1) ES2575206T3 (enExample)
GB (1) GB201020300D0 (enExample)
PL (1) PL2646040T3 (enExample)
RU (1) RU2013127665A (enExample)
WO (1) WO2012072374A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE046233T2 (hu) 2017-01-17 2020-02-28 Xvivo Perfusion Ab Szervkonzerválószer- és/vagy perfúziós oldatok
US11707600B2 (en) * 2020-11-18 2023-07-25 CardioDriven, Inc. Level set calibration and assurance for pulmonary artery pressure catheterization
CN117481629B (zh) * 2023-12-29 2024-03-26 成都水木医疗科技有限公司 一种多功能胶体渗透压仪及其测定方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1594697A (en) 1977-04-19 1981-08-05 Pharmacia Ab Oligosaccharide compositions for parenteral use
SE8900586L (sv) * 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
PT701455E (pt) 1993-06-04 2001-09-27 Biotime Inc Solucao semelhante a plasma
SE505499C2 (sv) * 1995-12-15 1997-09-08 Stiftelsen Facthor Förvaringslösning för organ och vävnad eller delar därav från människor och djur innehållande kalcium och nitroglycerin, användning därav samt förfarande för förvaring därmed
US6794124B2 (en) 1995-12-15 2004-09-21 Stiftelsen Facthor Preservation solution
US5902800A (en) 1998-03-27 1999-05-11 Glenpharma Dextran formulations and method for treatment of inflammatory joint disorders

Also Published As

Publication number Publication date
US20130316977A1 (en) 2013-11-28
US8969323B2 (en) 2015-03-03
JP6051164B2 (ja) 2016-12-27
CN103228285A (zh) 2013-07-31
WO2012072374A1 (en) 2012-06-07
JP2013544265A (ja) 2013-12-12
ES2575206T3 (es) 2016-06-27
EP2646040B1 (en) 2016-03-23
RU2013127665A (ru) 2015-01-10
CN103228285B (zh) 2016-06-01
DK2646040T3 (en) 2016-06-13
EP2646040A1 (en) 2013-10-09
PL2646040T3 (pl) 2017-04-28

Similar Documents

Publication Publication Date Title
BR112013026319A2 (pt) método e aparelho para o monitoramento de um tratamento de um paciente, preferivelmente para o monitoramento da hemodiálise, hemodiafiltração e/ou diálise peritoneal
DK3311827T3 (da) Nanopartikler, fremgangsmåde til fremstilling og anvendelse deraf som bærere for amfipatiske eller hydrofobe molekyler inden for det medicinske område, inklusiv cancerbehandling, samt fødevarerelaterede forbindelser
MX360317B (es) Derivados de exendina-4 funcionalizada.
AU2011328009A8 (en) Compounds and methods for treating pain
HK1220151A1 (zh) 用於将药物递送至靶部位的方法和设备
WO2010091376A3 (en) Devices and methods for perfusion therapy
MX359962B (es) Método y aparato para tratar a un paciente, ocluyendo intencionalmente un vaso sanguíneo, que incluye un método y un aparato para inducir la pérdida de peso en un paciente, ocluyendo intencionalmente la arteria celiaca.
EP2741806A4 (en) METHOD AND APPARATUS FOR BLOOD DIALYSIS
WO2012158437A3 (en) Cannula apparatus and ventricular assist systems using the cannula apparatus
WO2013022740A3 (en) Gpr35 ligands and the uses thereof
PL3260865T3 (pl) Sposób obróbki krwi, produktów krwiopochodnych i narządów
MX356025B (es) Uso de glicopirrolato para tratar taquicardia.
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
CA3010788A1 (en) Methods of administering vasopressors
EP4403220A3 (en) Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
GB201020300D0 (en) Product
MX2013007055A (es) Derivados de sanglifehrina y metodos para su produccion.
HK1194912A2 (en) Growth factor concentrate and the use thereof
PH12014500973A1 (en) Phosphatidylinositol 3-kinase inhibitors for the treatment of lymphoproliferative malignancies
MX2013012551A (es) Uso de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio en el tratamiento de enfermedades cardiovasculares.
WO2013052933A3 (en) Myosin binding protein- c for use in methods relating to diastolic heart failure
UA52107U (ru) Способ хирургического лечения туберкулеза легких
UA59839U (ru) Способ фракционного промывания брюшной полости при перитоните
UA97741C2 (ru) Способ восстановления кожных покровов при глубоких распространенных ожогах микроаутодермотрансплантатами
UA76568U (ru) Лечебно-столовая вода для лечения онкологических патологий, сахарного диабета, сердечно-сосудистых патологий, патологий кожи и снижения веса пациентов с избыточным весом

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)